Endocrinology in New Haven, CT
22 verified endocrinology doctors in New Haven.
Endocrinologists treat hormone-related conditions such as diabetes, thyroid disorders, and metabolic disease.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Howard Hochster, MD
Endocrinology
CMS Open Payments· $430,787 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$430,787
Total received
18
Transactions
9
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Howard Hochster do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Scott Gettinger, MD
Endocrinology
CMS Open Payments· $524,637 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$524,637
Total received
18
Transactions
5
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Scott Gettinger do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vincent Devita, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Erkut Bahceci, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Warren Shlomchik, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Brian Smith, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Charles Fuchs, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Peter Marks, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Stephanie Halene, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sarah Goldberg, MD
Endocrinology
CMS Open Payments· $2,949,038 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,949,038
Total received
62
Transactions
11
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Sarah Goldberg do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Frederick Wilson, MD
Endocrinology
CMS Open Payments· $31,000 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$31,000
Total received
5
Transactions
2
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total ranks around the 79th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Frederick Wilson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anish Sharda, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Lohith Gowda, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Noffar Bar, MD
Endocrinology
CMS Open Payments· $637,069 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$637,069
Total received
35
Transactions
5
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Noffar Bar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Aarti Bhatia, MD
Endocrinology
CMS Open Payments· $295,308 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$295,308
Total received
14
Transactions
5
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Aarti Bhatia do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Chiorazzi, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Cecchini, MD
Endocrinology
CMS Open Payments· $1,214,109 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,214,109
Total received
197
Transactions
14
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Michael Cecchini do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Layla Van Doren, MD
Endocrinology
CMS Open Payments· $23,729 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$23,729
Total received
24
Transactions
6
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total ranks around the 77th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Layla Van Doren do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Thomas Prebet, MD
Endocrinology
CMS Open Payments· $12,472 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$12,472
Total received
4
Transactions
1
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Thomas Prebet do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Grant, MD
Endocrinology
CMS Open Payments· $24.36 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$24.36
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 1,536 endocrinology doctors we've analyzed, about 57% received any industry payment (median $5,101 among those who did). This doctor's total is on the lower end — around the 45th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US endocrinology doctors.
Payments to Michael Grant do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Yifei Zhang, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Maureen Mcglennon, MD
Endocrinology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.